PDB Short entry for 1NH0
HEADER    HYDROLASE/HYDROLASE INHIBITOR           18-DEC-02   1NH0              
TITLE     1.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND      
TITLE    2 OUTSIDE THE ACTIVE SITE                                              
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEASE RETROPEPSIN;                                      
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: HIV-1 PROTEASE;                                             
COMPND   5 EC: 3.4.23.16;                                                       
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2;              
COMPND   9 CHAIN: I, J;                                                         
COMPND  10 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_TAXID: 11676;                                               
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   5 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   7 MOL_ID: 2;                                                           
SOURCE   8 SYNTHETIC: YES                                                       
KEYWDS    ASPARTYL PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS, INHIBITOR DESIGN,    
KEYWDS   2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX                                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    J.BRYNDA,P.REZACOVA,M.FABRY,M.HOREJSI,M.HRADILEK,M.SOUCEK,            
AUTHOR   2 J.KONVALINKA,J.SEDLACEK                                              
REVDAT   3   13-JUL-11 1NH0    1       VERSN                                    
REVDAT   2   24-FEB-09 1NH0    1       VERSN                                    
REVDAT   1   13-APR-04 1NH0    0                                                
JRNL        AUTH   J.BRYNDA,P.REZACOVA,M.FABRY,M.HOREJSI,R.STOURACOVA,          
JRNL        AUTH 2 J.SEDLACEK,M.SOUCEK,M.HRADILEK,M.LEPSIK,J.KONVALINKA         
JRNL        TITL   A PHENYLNORSTATINE INHIBITOR BINDING TO HIV-1 PROTEASE:      
JRNL        TITL 2 GEOMETRY, PROTONATION, AND SUBSITE-POCKET INTERACTIONS       
JRNL        TITL 3 ANALYZED AT ATOMIC RESOLUTION                                
JRNL        REF    J.MED.CHEM.                   V.  47  2030 2004              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   15056001                                                     
JRNL        DOI    10.1021/JM031105Q                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.03 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.03                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 6.00                           
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.0                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.131                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.130                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.165                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 2.500                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 2205                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 88225                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.122                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.122                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.157                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 2.500                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 1909                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 76731                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 1616                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 15                                            
REMARK   3   SOLVENT ATOMS      : 233                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 1839.62                 
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 1670.00                 
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 20                      
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 16567                   
REMARK   3   NUMBER OF RESTRAINTS                     : 20084                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.016                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.036                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.030                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.144                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.175                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.054                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.010                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.054                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.085                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER                        
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS:                                           
REMARK   3  ANISOTROPIC SCALING APPLIED BY THE METHOD OF PARKIN, MOEZZI & HOPE, 
REMARK   3  J.APPL.CRYST. 28 (1995) 53-56                                       
REMARK   4                                                                      
REMARK   4 1NH0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-DEC-02.                  
REMARK 100 THE RCSB ID CODE IS RCSB017861.                                      
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 12-NOV-01                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : 2                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID14-2                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9930                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
REMARK 200  DATA SCALING SOFTWARE          : XDS                                
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 88784                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.030                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 54.100                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.0                               
REMARK 200  DATA REDUNDANCY                : 9.800                              
REMARK 200  R MERGE                    (I) : 0.08900                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 10.5000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.03                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.06                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 93.3                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 5.20                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.59500                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 1.850                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: EPMR                                                  
REMARK 200 STARTING MODEL: 1VIK                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 36.64                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       14.45650            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       46.57350            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       33.28100            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       46.57350            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       14.45650            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       33.28100            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     ARG A  41    CG   CD   NE   CZ   NH1  NH2                        
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A   8   NE  -  CZ  -  NH1 ANGL. DEV. =   4.9 DEGREES          
REMARK 500    GLY A  17   C   -  N   -  CA  ANGL. DEV. = -14.9 DEGREES          
REMARK 500    GLN B   2   CG  -  CD  -  NE2 ANGL. DEV. =  24.5 DEGREES          
REMARK 500    GLY B  16   O   -  C   -  N   ANGL. DEV. = -12.3 DEGREES          
REMARK 500    GLY B  17   C   -  N   -  CA  ANGL. DEV. =  15.7 DEGREES          
REMARK 500    ARG B  41   NE  -  CZ  -  NH2 ANGL. DEV. =   3.0 DEGREES          
REMARK 500    ILE B  64   N   -  CA  -  CB  ANGL. DEV. =  14.2 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    PRO B  79       48.33    -81.88                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CHIRAL CENTERS                                             
REMARK 500                                                                      
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL                     
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY                      
REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR                        
REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE                                    
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN                            
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE                   
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)       
REMARK 500                                                                      
REMARK 500  M RES CSSEQI    IMPROPER   EXPECTED   FOUND DETAILS                 
REMARK 500    ILE B  84        24.5      L          L   OUTSIDE RANGE           
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A6082        DISTANCE =  5.39 ANGSTROMS                       
REMARK 610                                                                      
REMARK 610 MISSING HETEROATOM                                                   
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 610 I=INSERTION CODE):                                                   
REMARK 610   M RES C SSEQI                                                      
REMARK 610     BME B 5002                                                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 6001                
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 6002                
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 5001                
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 5002                
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC5                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF PEPTIDOMIMETIC         
REMARK 800  INHIBITOR KI2-PHE-GLU-GLU-NH2                                       
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC6                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN J OF PEPTIDOMIMETIC         
REMARK 800  INHIBITOR KI2-PHE-GLU-GLU-NH2                                       
DBREF  1NH0 A    1    99  UNP    P03367   POL_HV1BR       69    167             
DBREF  1NH0 B    1    99  UNP    P03367   POL_HV1BR       69    167             
DBREF  1NH0 I    1     5  PDB    1NH0     1NH0             1      5             
DBREF  1NH0 J    1     5  PDB    1NH0     1NH0             1      5             
SEQRES   1 A   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          
SEQRES   2 A   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 A   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          
SEQRES   4 A   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 A   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          
SEQRES   6 A   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 A   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          
SEQRES   8 A   99  GLN ILE GLY CYS THR LEU ASN PHE                              
SEQRES   1 B   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          
SEQRES   2 B   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 B   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          
SEQRES   4 B   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 B   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          
SEQRES   6 B   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 B   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          
SEQRES   8 B   99  GLN ILE GLY CYS THR LEU ASN PHE                              
SEQRES   1 I    5  KI2 PHE GLU GLU NH2                                          
SEQRES   1 J    5  KI2 PHE GLU GLU NH2                                          
HET    KI2  I   1      33                                                       
HET    NH2  I   5       1                                                       
HET    KI2  J   1      23                                                       
HET    NH2  J   5       1                                                       
HET    SO4  A6001       5                                                       
HET    SO4  B6002       5                                                       
HET    BME  A5001       4                                                       
HET    BME  B5002       1                                                       
HETNAM     KI2 3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC              
HETNAM   2 KI2  ACID                                                            
HETNAM     NH2 AMINO GROUP                                                      
HETNAM     SO4 SULFATE ION                                                      
HETNAM     BME BETA-MERCAPTOETHANOL                                             
FORMUL   3  KI2    2(C18 H19 N O5)                                              
FORMUL   3  NH2    2(H2 N)                                                      
FORMUL   5  SO4    2(O4 S 2-)                                                   
FORMUL   7  BME    2(C2 H6 O S)                                                 
FORMUL   9  HOH   *233(H2 O)                                                    
HELIX    1   1 GLY A   86  THR A   91  1                                   6    
HELIX    2   2 GLN A   92  GLY A   94  5                                   3    
HELIX    3   3 GLY B   86  THR B   91  1                                   6    
HELIX    4   4 GLN B   92  GLY B   94  5                                   3    
SHEET    1   1 3 THR B  96  ASN B  98  0                                        
SHEET    2   1 3 THR A  96  ASN A  98 -1  N  THR A  96   O  ASN B  98           
SHEET    3   1 3 GLN B   2  THR B   4 -1  N  ILE B   3   O  LEU A  97           
SHEET    1   5 7 GLY A  52  ILE A  66  0                                        
SHEET    2   5 7 LEU A  10  ILE A  15 -1  O  LYS A  14   N  GLU A  65           
SHEET    3   5 7 GLN A  18  LEU A  24 -1  O  GLN A  18   N  ILE A  15           
SHEET    4   5 7 ILE A  84  ILE A  85  1  N  ILE A  85   O  LEU A  23           
SHEET    5   5 7 VAL A  32  LEU A  33 -1  O  VAL A  32   N  ILE A  84           
SHEET    6   5 7 HIS A  69  VAL A  77  1  O  LEU A  76   N  LEU A  33           
SHEET    7   5 7 GLY A  52  ILE A  66 -1  N  ARG A  57   O  VAL A  77           
SHEET    1  14 7 GLY B  52  ILE B  66  0                                        
SHEET    2  14 7 LEU B  10  ILE B  15 -1  O  LYS B  14   N  GLU B  65           
SHEET    3  14 7 GLN B  18  LEU B  24 -1  O  GLN B  18   N  ILE B  15           
SHEET    4  14 7 ILE B  84  ILE B  85  1  N  ILE B  85   O  LEU B  23           
SHEET    5  14 7 VAL B  32  LEU B  33 -1  O  VAL B  32   N  ILE B  84           
SHEET    6  14 7 HIS B  69  VAL B  77  1  O  LEU B  76   N  LEU B  33           
SHEET    7  14 7 GLY B  52  ILE B  66 -1  N  ARG B  57   O  VAL B  77           
LINK         C   GLU I   4                 N   NH2 I   5     1555   1555  1.30  
LINK         C   GLU J   4                 N   NH2 J   5     1555   1555  1.24  
LINK         SG ACYS A  67                 S2 ABME A5001     1555   1555  2.00  
LINK         C   KI2 I   1                 N   PHE I   2     1555   1555  1.32  
LINK         C   KI2 J   1                 N   PHE J   2     1555   1555  1.33  
SITE     1 AC1  5 TRP A  42  PRO A  44  ARG A  57  HOH A6087                    
SITE     2 AC1  5 GLU B  34                                                     
SITE     1 AC2  6 HOH A6014  GLN B   2  ARG B  41  ASN B  98                    
SITE     2 AC2  6 HOH B6070  HOH B6106                                          
SITE     1 AC3  4 VAL A  11  THR A  12  CYS A  67  GLN B   7                    
SITE     1 AC4  3 THR B  12  CYS B  67  HOH B6105                               
SITE     1 AC5 30 ASP A  25  GLY A  27  ALA A  28  ASP A  29                    
SITE     2 AC5 30 ASP A  30  ILE A  47  GLY A  48  GLY A  49                    
SITE     3 AC5 30 ILE A  50  VAL A  82  ILE A  84  HOH A6010                    
SITE     4 AC5 30 HOH A6015  ARG B   8  LEU B  23  ASP B  25                    
SITE     5 AC5 30 GLY B  27  ALA B  28  ASP B  30  VAL B  32                    
SITE     6 AC5 30 ILE B  47  GLY B  48  GLY B  49  ILE B  50                    
SITE     7 AC5 30 VAL B  82  ILE B  84  HOH I   6  HOH I   7                    
SITE     8 AC5 30 HOH I   8  HOH I  10                                          
SITE     1 AC6 29 THR A   4  TRP A   6  PRO A  39  GLY A  40                    
SITE     2 AC6 29 ARG A  41  HOH A6064  LYS B  14  PRO B  44                    
SITE     3 AC6 29 LYS B  45  LYS B  55  VAL B  56  ARG B  57                    
SITE     4 AC6 29 CYS B  67  GLY B  68  GLN B  92  ILE B  93                    
SITE     5 AC6 29 GLY B  94  HOH B6030  HOH B6034  HOH B6052                    
SITE     6 AC6 29 HOH B6079  HOH B6085  HOH B6115  HOH J   8                    
SITE     7 AC6 29 HOH J  22  HOH J  93  HOH J 152  HOH J 177                    
SITE     8 AC6 29 HOH J 225                                                     
CRYST1   28.913   66.562   93.147  90.00  90.00  90.00 P 21 21 21    8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.034587  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.015024  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.010736        0.00000